» Articles » PMID: 32821854

Predictably Unequal: Understanding and Addressing Concerns That Algorithmic Clinical Prediction May Increase Health Disparities

Overview
Journal NPJ Digit Med
Date 2020 Aug 22
PMID 32821854
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The machine learning community has become alert to the ways that predictive algorithms can inadvertently introduce unfairness in decision-making. Herein, we discuss how concepts of algorithmic fairness might apply in healthcare, where predictive algorithms are being increasingly used to support decision-making. Central to our discussion is the distinction between algorithmic fairness and algorithmic bias. Fairness concerns apply specifically when algorithms are used to support polar decisions (i.e., where one pole of prediction leads to decisions that are generally more desired than the other), such as when predictions are used to allocate scarce health care resources to a group of patients that could all benefit. We review different fairness criteria and demonstrate their mutual incompatibility. Even when models are used to balance benefits-harms to make optimal decisions for individuals (i.e., for non-polar decisions)-and fairness concerns are not germane-model, data or sampling issues can lead to biased predictions that support decisions that are differentially harmful/beneficial across groups. We review these potential sources of bias, and also discuss ways to diagnose and remedy algorithmic bias. We note that remedies for algorithmic fairness may be more problematic, since we lack agreed upon definitions of fairness. Finally, we propose a provisional framework for the evaluation of clinical prediction models offered for further elaboration and refinement. Given the proliferation of prediction models used to guide clinical decisions, developing consensus for how these concerns can be addressed should be prioritized.

Citing Articles

Harnessing digital health data for suicide prevention and care: A rapid review.

Bennett-Poynter L, Kundurthi S, Besa R, Joyce D, Kormilitzin A, Shen N Digit Health. 2025; 11:20552076241308615.

PMID: 39996066 PMC: 11848906. DOI: 10.1177/20552076241308615.


Assessing Algorithm Fairness Requires Adjustment for Risk Distribution Differences: Re-Considering the Equal Opportunity Criterion.

Hegarty S, Linn K, Zhang H, Teeple S, Albert P, Parikh R medRxiv. 2025; .

PMID: 39974139 PMC: 11838655. DOI: 10.1101/2025.01.31.25321489.


Advancing Ethical Considerations for Data Science in Injury and Violence Prevention.

Idaikkadar N, Bodin E, Cholli P, Navon L, Ortmann L, Banja J Public Health Rep. 2025; 333549241312055.

PMID: 39834075 PMC: 11748135. DOI: 10.1177/00333549241312055.


Participant Contributions to Person-Generated Health Data Research Using Mobile Devices: Scoping Review.

Song S, Ashton M, Yoo R, Lkhagvajav Z, Wright R, Mathews D J Med Internet Res. 2025; 27:e51955.

PMID: 39832140 PMC: 11791458. DOI: 10.2196/51955.


Heartificial intelligence: in what ways will artificial intelligence lead to changes in cardiology over the next 10 years.

Brown S Br J Cardiol. 2024; 31(2):015.

PMID: 39555461 PMC: 11562571. DOI: 10.5837/bjc.2024.015.


References
1.
Lesko L, Atkinson Jr A . Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001; 41:347-66. DOI: 10.1146/annurev.pharmtox.41.1.347. View

2.
Rajkomar A, Hardt M, Howell M, Corrado G, Chin M . Ensuring Fairness in Machine Learning to Advance Health Equity. Ann Intern Med. 2018; 169(12):866-872. PMC: 6594166. DOI: 10.7326/M18-1990. View

3.
Matsuno R, Costantino J, Ziegler R, Anderson G, Li H, Pee D . Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011; 103(12):951-61. PMC: 3119648. DOI: 10.1093/jnci/djr154. View

4.
Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C . Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989; 81(24):1879-86. DOI: 10.1093/jnci/81.24.1879. View

5.
Ankerst D, Hoefler J, Bock S, Goodman P, Vickers A, Hernandez J . Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology. 2014; 83(6):1362-7. PMC: 4035700. DOI: 10.1016/j.urology.2014.02.035. View